Ignite Creation Date:
2024-05-06 @ 9:55 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03110510
Status:
WITHDRAWN
Last Update Posted:
2022-06-15
First Post:
2017-04-07
Brief Title:
FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer BTC Patients Who Were Failed After Gemcitabine Containing Chemotherapy A Phase II Single Arm Prospective Study
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2017-02-094
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Samsung Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Joon Oh Park
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None